Direct and Indirect Effects of Rotavirus Vaccination: Comparing Predictions from Transmission Dynamic Models
Open Access
- 13 August 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (8) , e42320
Abstract
Early observations from countries that have introduced rotavirus vaccination suggest that there may be indirect protection for unvaccinated individuals, but it is unclear whether these benefits will extend to the long term. Transmission dynamic models have attempted to quantify the indirect protection that might be expected from rotavirus vaccination in developed countries, but results have varied. To better understand the magnitude and sources of variability in model projections, we undertook a comparative analysis of transmission dynamic models for rotavirus. We fit five models to reported rotavirus gastroenteritis (RVGE) data from England and Wales, and evaluated outcomes for short- and long-term vaccination effects. All of our models reproduced the important features of rotavirus epidemics in England and Wales. Models predicted that during the initial year after vaccine introduction, incidence of severe RVGE would be reduced 1.8–2.9 times more than expected from the direct effects of the vaccine alone (28–50% at 90% coverage), but over a 5-year period following vaccine introduction severe RVGE would be reduced only by 1.1–1.7 times more than expected from the direct effects (54–90% at 90% coverage). Projections for the long-term reduction of severe RVGE ranged from a 55% reduction at full coverage to elimination with at least 80% coverage. Our models predicted short-term reductions in the incidence of RVGE that exceeded estimates of the direct effects, consistent with observations from the United States and other countries. Some of the models predicted that the short-term indirect benefits may be offset by a partial shifting of the burden of RVGE to older unvaccinated individuals. Nonetheless, even when such a shift occurs, the overall reduction in severe RVGE is considerable. Discrepancies among model predictions reflect uncertainties about age variation in the risk and reporting of RVGE, and the duration of natural and vaccine-induced immunity, highlighting important questions for future research.Keywords
This publication has 49 references indexed in Scilit:
- Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus VaccineNew England Journal of Medicine, 2006
- Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus GastroenteritisNew England Journal of Medicine, 2006
- Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillanceBMJ, 1999
- The Protective Effectiveness of Natural Rotavirus Infection in an American Indian PopulationThe Journal of Infectious Diseases, 1998
- Rotavirus Infection in Infants as Protection against Subsequent InfectionsNew England Journal of Medicine, 1996
- Food poisoning: notifications, laboratory reports, and outbreaks--where do the statistics come from and what do they mean?1996
- Evidence that Protection against Rotavirus Diarrhea after Natural Infection Is Not Dependent on Serotype-Specific Neutralizing AntibodyThe Journal of Infectious Diseases, 1992
- Interpretation and Estimation of Vaccine Efficacy under HeterogeneityAmerican Journal of Epidemiology, 1992
- EPIDEMIOLOGY OF ROTA VIRUS INFECTION AND GASTROENTERITIS IN PROSPECTIVELY MONITORED ARGENTINE FAMILIES WITH YOUNG CHILDRENAmerican Journal of Epidemiology, 1989
- Assessment of the Protective Efficacy of Vaccines against Common Diseases Using Case-Control and Cohort StudiesInternational Journal of Epidemiology, 1984